Good morning :)
Switch to
Place Order

SeQuent Scientific Ltd

SEQUENT
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,039 cr, stock is ranked 398
Moderate RiskStock is 2.97x as volatile as Nifty
285.152.95 (-1.02%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,039 cr, stock is ranked 398
Moderate RiskStock is 2.97x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
73.76
PB RatioPB Ratio
8.94
Dividend YieldDiv. Yield
0.18%
Sector PESector PE
40.17
Sector PBSector PB
5.68
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

0%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SeQuent Scientific Limited is a holding company that operates in pharmaceutical sector.

Investor PresentationView older 

Feb 3, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020211.291.051.191.370.420.050.070.10
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transactions 
Announced OnJul 30, 2021

Sequent Scientific Limited has informed the Exchange about related Party Transactions | Download

Sequent Scientific Limited has informed the Exchange about related Party Transactions | Download

Press Release 
Announced OnJul 14, 2021

Sequent Scientific Limited has informed the Exchange regarding a press release dated July 14, 2021, titled "Press Release SeQuent announced EUGMP approval for its tablets dosage form in Turkey". | Download

Sequent Scientific Limited has informed the Exchange regarding a press release dated July 14, 2021, titled "Press Release SeQuent announced EUGMP approval for its tablets dosage form in Turkey". | Download

Cash Dividend 
Ex. DateAug 21, 2019

Final • Div/Share: ₹ 0.2

See all events